---
schema_version: "secwatch.filing_event.v1"
accession: "0000950170-25-086246"
form_type: "8-K"
ticker: "ACRV"
cik: "0001781174"
company_name: "Acrivon Therapeutics, Inc."
filed_at: "2025-06-13T23:59:59+00:00"
generated_at: "2026-05-19T08:46:28.794484+00:00"
event_type: "other"
sentiment: "neutral"
materiality_score: 0.15
calibrated_materiality_score: 0.15
confidence: "high"
source: SEC EDGAR
---

# Acrivon stockholders elect three Class III directors and ratify PwC as auditor

## Summary
- Quorum of 29,659,010 shares (94.59%) present at 2025 annual meeting on June 13.
- Peter Blume-Jensen (26,612,623 for), Derek DiRocco (24,606,548), Santhosh Palani (26,246,868) elected as Class III directors.
- Ratification of PricewaterhouseCoopers LLP as auditor for FY2025: 29,653,924 for, 3,673 against, 1,413 abstain.

## SEC filing metadata
- accession: 0000950170-25-086246
- form_type: 8-K
- ticker: ACRV
- cik: 0001781174
- company_name: Acrivon Therapeutics, Inc.
- filed_at: 2025-06-13T23:59:59+00:00
- event_type: other
- sentiment: neutral
- materiality_score: 0.15
- calibrated_materiality_score: 0.15
- confidence: high
- sec_items: 5.07
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1781174/000095017025086246/0000950170-25-086246-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1781174/000095017025086246/acrv-20250613.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000950170-25-086246
- JSON: https://secwatch.observer/filing/0000950170-25-086246.json
- Plain text: https://secwatch.observer/filing/0000950170-25-086246.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.